Navigation Links
Michael D. Farley Appointed Chief Operating Officer of Lupus Foundation of America, Inc.
Date:3/26/2008

WASHINGTON, March 26 /PRNewswire-USNewswire/ -- Michael D. Farley has joined the Lupus Foundation of America, Inc. national office in Washington, DC as the organization's Chief Operating Officer, where he will be responsible for the Foundation's overall organizational administration and field development. Farley has expertise in administering major national voluntary health organizations, including serving most recently as the interim CEO and Chief Community and Corporate Relations Officer for the American Diabetes Association. He also has served as Senior Vice President of Development with the USO World Headquarters, and Vice President for Field Development at the American Red Cross.

Farley will be responsible for the LFA's organization-wide operations and development, including research, public and professional education, internal and external communications, marketing, fund development, strategic partnerships, public policy, field operations, finance, and administration.

Founded more than 30 years ago, the LFA is the foremost national nonprofit voluntary health organization dedicated to finding the causes of and cure for lupus and for providing support, services, and hope to all people affected by lupus. The LFA operates programs of research, education, and advocacy, and has a nationwide network of nearly 300 chapters, branches, and support groups.

In announcing Farley's appointment, LFA President and CEO Sandra C. Raymond cited Farley's extensive expertise in nonprofit administration and field development. "Michael Farley has 25 years of leadership in senior management positions with major national nonprofit organizations," Raymond said. "His experience will be instrumental in helping the LFA meet its critical priorities which are focused on increasing public and private sector support for medical research and expanding support and services to individuals who are affected by lupus."

Farley said this truly is an exciting time to join the Foundation. "New research initiatives hold promise for extraordinary advances in diagnosing and treating lupus. New information is being discovered about the causes of lupus, directly affecting more than 1.5 million Americans. New therapies are ready to emerge that will help manage and control this life-diminishing and life-threatening disease," said Farley. "The LFA is preparing to take advantage of these wonderful advances, and I am honored to do my part in supporting our leadership, scientists, and patient advocates across the country."

Lupus results from an unbalanced immune system that can be destructive to any organ or tissue in the body. Lupus is unpredictable and potentially fatal, yet no satisfactory treatment exists. For more information about lupus and the LFA, go online to lupus.org or call toll free 1-888-38-LUPUS to obtain a free information packet.


'/>"/>
SOURCE Lupus Foundation of America
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Michael Moores SiCKO Becomes the Third Highest Grossing Documentary of All Time Surpassing An Inconvenient Truth
2. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
3. Clarient Names Michael J. Pellini, M.D. Chief Operating Officer
4. Digital Healthcare Announces Dr. Michael Fleming Joins Executive Team as Medical Director
5. Michael J. Fox Foundation Commits Up to $2 Million for PD Drug Development Under Target Validation 2008
6. BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales
7. BioSeek Appoints Michael C. Venuti, Ph.D., Chief Executive Officer
8. Irene Hegeman Richard, MD, Appointed Senior Medical Advisor to The Michael J. Fox Foundation
9. Actress Jenifer Lewis, Authors Dr. Michael Eric Dyson and Susan Taylor Among Featured Speakers for Senator Hughes Behavioral Mental Health Summit
10. Michael J. Fox Foundation Launches Rapid Response Innovation Awards 2008 Following Strong Inaugural Year Response
11. Siemens Medical Solutions Michael Long Recognized as one of Computerworlds 2008 Premier 100 IT Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... TopConsumerReviews.com recently gave a best-in-class 5 ... , The healthcare industry in the United States has undergone major changes over the ... needing to have a doctor’s order to get a blood test or other lab ...
(Date:8/16/2017)... ... August 16, 2017 , ... Women’s Excellence in ... pain. In addition to oncology services, the new center will specialize in ... heavy bleeding during menstruation), uterine fibroids, and uterine and pelvic adhesions (scar tissue). ...
(Date:8/16/2017)... ... August 16, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, Prache ... effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “Prache ...
(Date:8/16/2017)... ... ... Chain”: an inspirational story for those shackled by the chains of a broken life. ... writer and a woman of great faith and wisdom. She is a great motivational ... born and raised in Vero Beach, Florida and has dedicated her life and ministry to ...
(Date:8/15/2017)... (PRWEB) , ... August 15, 2017 , ... ... of disease. It’s reaching out to a patient who feels isolated. It’s developing ... amid madness. , WesternU President Daniel R. Wilson, MD, PhD, invited three renowned ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... as president, effective Aug. 7, 2017. ... to pursue other interests and will serve as president emeritus ... has served us in multiple leadership roles since he joined ... 2015 and has provided decisive, strategic leadership which continues to ...
(Date:8/3/2017)... -- Opioid addiction and other drugs of abuse, blood poisoning ... outcomes, were problems taken on directly as laboratory professionals, ... them, met this week. This according to Kalorama Information. ... abuse, procalcitonin and acute kidney injury were key focuses ... in San Diego, CA.  Mechanisms ...
(Date:8/1/2017)... CerSci Therapeutics , a non-opioid drug development firm based ... notice from the National Institute on Drug Abuse (NIDA) ... has been awarded a Direct-to-Phase II Small Business Innovation ... an additional $1,000,000 to follow in 2018. These funds ... lead non-opioid drug candidate CT-044 to the Food and ...
Breaking Medicine Technology: